---
title: "BCL11A"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene BCL11A"
tags: ['BCL11A', 'TranscriptionFactor', 'LymphoidDevelopment', 'Cancer', 'SickleCellAnemia', 'Thalassemia', 'NeurodevelopmentalAbnormalities', 'DrugTherapies']
---

## Gene BCL11A
- **Function:** The BCL11A gene encodes a transcription factor that plays a crucial role in lymphoid development and is involved in the regulation of globin gene expression, T-cell differentiation, and tumor suppression.
- **External IDs:** 
    - HGNC: 13299
    - NCBI Entrez: 53335
    - Ensembl: ENSG00000164879
    - OMIM: 606557
    - UniProtKB/Swiss-Prot: Q9H165
- **Aliases**: CBAH, CTIP1, EVI9, ZNF856B, hBCL-5
- **AA mutation list:**
    - c.1011G>A: p.Asp337Asn, rs41298401
    - c.1222G>T: p.Glu408Ter, rs201768883
    - c.163delG: p.Val55SerfsTer29, rs587777904
- **Mutation type:**
    - Missense mutation
    - Nonsense mutation
    - Frameshift mutation
- **Somatic SNVs/InDels:** 
    - c.691G>T: p.Val231Leu, rs146018460
    - c.1784G>A: p.Arg595Gln, rs755912677
    - c.1934C>G: p.Ala645Gly, rs786201398
- **Related disease:** BCL11A is associated with many disorders like cancer, sickle cell anemia, thalassemia, and neurodevelopmental abnormalities.
- **Treatment and prognosis:** Currently, there is no specific treatment for BCL11A-related disorders. Treatment is focused on symptom management and supportive care.
- **Drug response:** Limited studies have shown promising results for anti-cancer therapies targeting BCL11A. However, further research is necessary to develop reliable drug therapies for BCL11A-related disorders.
- **Related papers:**
    - Subject: Role of BCL11A in cancer therapy
      - [Author: Zhou L et al.]([Click](https://pubmed.ncbi.nlm.nih.gov/30998606/))
      - DOI: 10.1016/j.pharmthera.2019.04.003

    - Subject: BCL11A and its association with sickle cell anemia
      - [Author: Bauer DE et al.]([Click](https://pubmed.ncbi.nlm.nih.gov/27373830/))
      - DOI: 10.1016/j.cmet.2016.06.012

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**